908 Devices Shares Rise as FY Revenue Is Projected to Hit High End of Outlook

Dow Jones
01/20
 

By Connor Hart

 

Shares of 908 Devices opened higher after the company said it expects full-year revenue to come in at the high end of its previously guided range.

The stock was trading hands at $6.28 in morning trading Tuesday, up 15%. Shares have more than doubled over the past year.

The maker of chemical-analysis devices before the bell said it expects revenue of about $56 million in 2025, marking a 17% increase from the previous year. It had previously forecast full-year revenue of $54 million to $56 million. Analysts are expecting $54.8 million, according to FactSet.

For the fourth quarter, 908 Devices expects revenue to climb about 20% year over year, to $17.2 million. The company attributed the gain to continued outperformance in the U.S., ramping international adoption of products, and sales to federal and defense customers.

"In 2025, we transformed our company into a stronger, simpler and more profitable financial model focused on frontline chemical detection," Chief Executive Kevin Knopp said.

908 Devices said it plans to report its full fourth-quarter and full-year results later this quarter, at which time it will provide its 2026 outlook.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

January 20, 2026 09:53 ET (14:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10